Authors:
Gallieni, M
Cozzolino, M
Carpani, P
Zoni, U
Brancaccio, D
Citation: M. Gallieni et al., Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients, J NEPHROL, 14(3), 2001, pp. 176-183
Authors:
Bellotti, V
Gallieni, M
Giorgetti, S
Brancaccio, D
Citation: V. Bellotti et al., Dynamic of beta(2)-microglobulin fibril formation and reabsorption: The role of proteolysis, SEMIN DIAL, 14(2), 2001, pp. 117-122
Authors:
Brancaccio, D
Gallieni, M
Niwa, T
Braidotti, P
Coggi, G
Citation: D. Brancaccio et al., Ultrastructural localization of advanced glycation end products and beta 2-microglobulin in dialysis amyloidosis, J NEPHROL, 13(2), 2000, pp. 129-136
Authors:
Gallieni, M
Brancaccio, D
Antonucci, F
Bellinghieri, G
Carpani, P
Cozzolino, M
D'Agostino, F
Del Mastro, G
Mallamace, A
Memoli, B
Citation: M. Gallieni et al., Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial, CLIN NEPHR, 53(3), 2000, pp. 188-193
Citation: M. Gallieni et al., Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder, KIDNEY INT, 57(4), 2000, pp. 1776-1777
Authors:
Gallieni, M
Braidotti, P
Cozzolino, M
Romagnoli, S
Carpani, P
Citation: M. Gallieni et al., Acute tubulo-interstitial nephritis requiring dialysis associated with intermittent rifampicin use: case report, INT J ARTIF, 22(7), 1999, pp. 477-481
Citation: M. Gallieni, Iron in the treatment of anemia in dialysis patients: an important supportto erythropoietin, INT J ARTIF, 21(11), 1998, pp. 681-686